Trimethoprim, Sulfamethoxazole Drug Combination

EsbL ; Escherichia coli







30 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35610764 Urinary Tract Infections in Long-term Care: Evaluation of Uropathogens, Antibiotic Susceptibility, and Empiric Treatment. 2022 Jun 1 1
2 33719123 Molecular typing and prevalence of extended-spectrum β-lactamase genes in diarrhoeagenic Escherichia coli strains isolated from foods and humans in Mashhad, Iran. 2021 Oct 1
3 33897921 Intestinal Carriage of Extended-Spectrum β-Lactamase- (ESBL-) Possessing Escherichia coli and Klebsiella Species among Nepalese Health Science and Non-Health Science Students. 2021 1
4 32547121 Gastrointestinal Tract Colonization Rate of Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Enterobacteriaceae and Associated Factors Among Hospitalized Patients in Arba Minch General Hospital, Arba Minch, Ethiopia. 2020 1
5 32566057 The Clinical Significance of High Antimicrobial Resistance in Community-Acquired Urinary Tract Infections. 2020 1
6 31429616 Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli in children: a case control study. 2019 Nov - Dec 1
7 31821338 The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. 2019 1
8 28992981 Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options. 2018 Apr 13 1
9 29409967 Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates. 2018 Mar - Apr 1
10 28368864 Characterization of ESBL-producing Escherichia coli recovered from companion dogs in Tai'an, China. 2017 Mar 31 1
11 26513341 Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options. 2016 May 1
12 27367005 Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance. 2016 Jun 30 1
13 27769180 Comparison of antimicrobial resistance patterns of ESBL and non ESBL bacterial isolates among patients with secondary peritonitis at Bugando Medical Centre, Mwanza - Tanzania. 2016 Oct 21 1
14 26283835 Phenotypic detection of extended spectrum β-lactamase and Amp-C β-lactamase producing clinical isolates in a Tertiary Care Hospital: A preliminary study. 2015 Jul-Dec 1
15 24666610 Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria. 2014 Mar 25 1
16 24856867 Prevalence and genotypes of extended spectrum beta-lactamases in Enterobacteriaceae isolated from human stool and chicken meat in Hamburg, Germany. 2014 Jul 1
17 25179392 Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae. 2014 Dec 1
18 25492650 [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations]. 2014 Oct 1
19 24274894 Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. 2013 Nov 25 1
20 24292287 Prevalence and antimicrobial susceptibility pattern of ESBL producing isolates. 2013 Oct 1
21 24940337 Antibiogram and plasmid profiling of carbapenemase and extended spectrum Beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in Abeokuta, South western, Nigeria. 2013 Dec 1
22 22882781 Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. 2012 Dec 2
23 20387724 [Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region]. 2010 Feb 1
24 21184671 Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania. 2010 Dec 24 2
25 18423165 [Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study]. 2008 Apr 12 1
26 17933257 [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp]. 2007 Jul 1
27 16501056 In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli. 2006 Apr 1
28 15574469 Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel. 2005 Jan 2
29 17642726 Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. 2004 Jul-Sep 1
30 11320450 Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. 2001 May 15 1